What is Kelker Pharma?
Kelker Pharma operates as a cGMP-certified contract manufacturer, providing comprehensive production solutions for capsules, tablets, powders, and nutritional bars. By leveraging advanced manufacturing and packaging infrastructure, the company delivers high-efficiency services tailored to the complex requirements of the nutraceutical and pharmaceutical industries. Its commitment to rigorous standard operating procedures, combined with organic, Kosher, and Halal certifications, positions Kelker Pharma as a high-quality partner for brands seeking reliable, large-scale production capabilities. The company's focus on speed and precision ensures it remains a critical link in the global health and wellness supply chain.
How much funding has Kelker Pharma raised?
Kelker Pharma has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Kelker Pharma
PPP
Public-Private Partnership
What's next for Kelker Pharma?
Following this late-stage financing, Kelker Pharma is well-positioned to accelerate its operational footprint and enhance its technological capabilities. The strategic allocation of this capital will likely focus on optimizing production throughput and expanding its service portfolio to meet the rising demand for specialized delivery forms. As the company matures, the focus will shift toward deepening its market penetration and maintaining its competitive edge through continued investment in state-of-the-art machinery and quality assurance protocols. This growth phase is expected to solidify Kelker Pharma's reputation as a premier provider in the contract manufacturing landscape, enabling it to scale alongside its diverse client base.
See full Kelker Pharma company page
